Core Viewpoint - Blue Arrow Aerospace is leading the charge to become the first publicly listed commercial aerospace company in China by submitting its IPO prospectus, despite currently being in a loss-making position [1][4]. Company Overview - Blue Arrow Aerospace, founded in 2015, focuses on the research, development, and production of liquid oxygen-methane engines and launch vehicles, as well as providing commercial rocket launch services [4]. - The company aims to raise 7.5 billion yuan through its IPO, with funds allocated to enhancing reusable rocket capacity and technology [4]. Financial Performance - Blue Arrow Aerospace has reported cumulative losses of approximately 3.465 billion yuan from 2022 to the first half of 2025 [6]. - Revenue figures for the reporting period are as follows: 782,900 yuan in 2022, 3.9521 million yuan in 2023, 4.2783 million yuan in 2024, and 36.4319 million yuan in the first half of 2025 [7]. - The net profit attributable to the company for the same periods were -800.4 million yuan, -1.188 billion yuan, -876 million yuan, and -597 million yuan respectively [7]. Research and Development - The company has invested approximately 2.289 billion yuan in R&D over three and a half years, with annual R&D expenses of 487 million yuan, 830 million yuan, 613 million yuan, and 360 million yuan [8]. - As of June 30, 2025, Blue Arrow Aerospace employed 404 R&D personnel, accounting for 33.28% of its total workforce [8]. Market Context - The commercial aerospace sector is experiencing accelerated competition for IPOs, with several companies, including Yixin Aerospace and Xinghe Power, also in the listing guidance phase [12]. - The market is expected to grow significantly due to the expanding applications of satellites in communication, navigation, and remote sensing, particularly in 5G and IoT sectors [12]. Regulatory Environment - The Chinese government has been supportive of the commercial aerospace sector, with recent policies aimed at facilitating IPOs for companies in this field [13]. - The introduction of the "1+6" reform measures by the China Securities Regulatory Commission in June 2025 has expanded the eligibility for companies in cutting-edge technology sectors, including commercial aerospace, to list on the Sci-Tech Innovation Board [13].

Core Viewpoint - Blue Arrow Aerospace Technology Co., Ltd. has received acceptance for its IPO on the Sci-Tech Innovation Board, marking it as the first commercial rocket company to achieve this under the new listing rules [1][15]. Group 1: Company Overview - The company aims to build a full industrial chain centered on medium and large reusable liquid oxygen-methane launch vehicles, focusing on R&D, manufacturing, testing, and launching [1][16]. - Founded in June 2015 and transformed into a joint-stock company in March 2019, Blue Arrow Aerospace is headquartered in Beijing with a registered capital of 360 million yuan [1][16]. - The company has become a leading commercial aerospace enterprise in China, specializing in the R&D and production of liquid oxygen-methane engines and launch vehicles, and providing commercial launch services [1][16]. Group 2: Product Development - The Zhuque-2 series medium liquid oxygen-methane launch vehicle is the first liquid-fueled rocket in China's private commercial aerospace sector to enter mass production and commercial use [2][17]. - The Zhuque-3 medium-large reusable launch vehicle successfully completed its maiden flight and entered orbit, becoming China's first reusable rocket to achieve this milestone [2][17]. - The company has established intelligent manufacturing bases in Huzhou, Jiaxing, and Wuxi, and has produced over 140 units of its independently developed "Tianque" series liquid oxygen-methane engines [2][17]. Group 3: Financial Performance - The company has not yet achieved profitability, with reported revenues of 780,000 yuan, 3.95 million yuan, 4.28 million yuan, and 36.43 million yuan for the years 2022, 2023, 2024, and the first half of 2025, respectively [3][18]. - The net losses for the same periods were -80.37 million yuan, -118.75 million yuan, -87.59 million yuan, and -59.65 million yuan [3][18]. - The company has maintained high R&D expenditures, with amounts of 487.22 million yuan, 830.43 million yuan, 612.56 million yuan, and 359.59 million yuan over the same periods [3][18]. Group 4: R&D and Innovation - Cumulatively, the company has invested 2.2898 billion yuan in R&D from 2022 to the first half of 2025, with R&D personnel accounting for 32.98% of the total workforce as of December 31, 2024 [5][19]. - The company holds 267 patents related to liquid-fueled rockets that are applicable to its main business and can be industrialized [5][19]. Group 5: IPO Fund Utilization - The IPO aims to raise 7.5 billion yuan, which will be allocated to two projects: enhancing the production capacity of reusable rockets and improving reusable rocket technology [15][29].